clinical trial | Alzheimer's, ADHD, Autism, Brain Injury Treatment, Mood Disorders New Jersey: The NeuroCognitive Institute

Underutilization Of Brain Amyloid Scans Drives Cost And Hurts Alzheimer’s Disease Care

LONDON, July 16, 2017 /PRNewswire-USNewswire/ — Research reported at the Alzheimer’s Association International Conference (AAIC) 2017 in London highlighted the clinical value of amyloid-β PET scans, which detect the presence of amyloid-beta plaques in the brain – one
Read More

Phase II Clinical Trial for Treatment of Mild Alzheimer’s Disease

U.S. Study Participants Aged 60 to 85 with Mild Dementia Needed TEL AVIV, March 7, 2017 /PRNewswire/ – Neurim Pharmaceuticals Ltd. announced today that they are seeking up to 500 U.S. patients with mild Alzheimer’s Disease for the start of a Phase II Clinical trial of a ne
Read More